Revascularization strategies in acute myocardial infarction: A meta-analysis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 12, 2004, Pages 663-671

  Bouzamondo, Anissa ^a   Damy, T ^a   Montalescot, G ^a   Lechat, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Angio plasty; GpIIb IIIa blockers; Metaanalysis; Myocardial infarction; Randomized trials; Stent; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO;

ACUTE HEART INFARCTION; ADJUVANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY STENT; DEATH; DRUG DOSE REDUCTION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 10344225617     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42663     Document Type: Article

References (32)

1. The PARADIGM Investigators 1998a Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. J Am Coll Cardiol 32: 2003-2010
2. The RESTORE Investigators 1997a Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation 96: 1445-1453
3. The ASSENT-3 Investigators 2001 Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358: 605-613
4. The EPILOG Investigators 1997b Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 336: 1689-1696
5. The EPISTENT Investigators 1998b Randomised placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 352: 87-92
6. The SPEED Group 2000 Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation 101: 2788-2794
7. The EPIC Investigators 1994 Use of a monoclonal anti-body directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 330: 956-961
8. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E 1999 Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI 14 trial. The TIMI 14 Investigators). Circulation 99: 2720-2732
9. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF 1998 A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 31: 1234-1239
10. Brener SJ, Barr LA, Burchenal JE, Wolski KE, Effron MB, Topol EJ 1999 Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty RAPPORT investigators. ReoPro and Primary PTCA Organization and Randomized Trial. Am J Cardiol 84: 728-730
11. Brener SJ, Zeymer U, Adgey AA, Vrobel TR, Ellis SG, Neuhaus KL, Juran N, Ivanc TB, Ohman EM, Strony J, Kitt M, Topol EJ 2002 Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. J Am Coll Cardiol 39: 377-386
12. Dalby M, Bouzamondo A, Lechat P, Montalescot G 2003 Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108: 1809-1814
13. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC 1999 Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341: 1949-1956
14. Kawashima A, Nishida Y, Inoue N, Tanaka S, Kawamoto A, Miyazaki H, Tanaka N, Kato O, Okada T, Furukawa K, Timai H 1999 Quantitative angiographic analysis of restenosis of primary stenting using wiktor stent for acute myocardial infarction: results from a multicenter randomized PRISAM study. Circulation 100 (Suppl I): 1-856
15. Kleiman NS, Ohman EM, Califf RM, George BS, Kereiakes D, Aguirre FV, Weisman H, Schaible T, Topol EJ 1993 Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI 8) Pilot Study. J Am Coll Cardiol 22: 381-389
16. Lee CW, Moon DH, Hong MK, Lee JH, Choi SW, Yang HS, Kim JJ, Park SW, Park SJ 2002 Effect of abciximab on myocardial salvage inpatients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 90: 1243-1246
17. Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, Spaulding CM, Boulenc JM, Lipiecki J, Lafont A, Brunel P, Grollier G, Koning R, Coste P, Favereau X, Lancelin B, Van Belle E, Serruys P, Monassier JP, Raynaud P 2000 A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM2 Investigators. J Am Coll Cardiol 35: 1729-1736
18. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, Choussat R, Pinton P 2001 Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344: 1895-1903
19. Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schomig A 1998 Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left veritricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 98: 2695-2701
20. Neumann FJ, Kastrati A, Schmitt C, Blasini R, Hadamitzky M, Mehilli J, Gawaz M, Schleef M, Seyfarth M, Dirschinger J, Schomig A 2000 Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 35: 915-921
21. Ohman EM, Kleiman NS, Gacioch G, Worley SJ, Navetta FI, Talley JD, Anderson HV, Ellis SG, Cohen MD, Spriggs D, Miller M, Kereiakes D, Yakubov S, Kitt MM, Sigmon KN, Califf RM, Krucoff MW, Topol EJ 1997 Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 95: 846-854
22. Rodriguez A, Bernardi V, Fernandez M, Mauvecin C, Ayala F, Santaera O, Martinez J, Mele E, Roubin GS, Palacios I, Ambrose JA 1998 In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. Am J Cardiol 81: 1286-1291
23. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Smith SC Jr 1999 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100: 1016-1030
24. Saito S, Hosokawa G, Tanaka S, Nakamura S 1999 Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Intervent 48: 262-268
25. Scheller B, Hennen B, Severin-Kneib S, Ozbek C, Schieffer H, Markwirth T 2001 Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction. Am J Med 110: 1-6
26. Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, Munger MA, Gardner SF, Nappi JM 2001 New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 35: 589-617
27. Stone GW 1998 Stenting and IIb/IIIa receptor blockade in acute myocardial infarction: an introduction to the CADILLAC Trial. J Invasive Cardiol 10: 36B-47B
28. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ 2002 Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346: 957-966
29. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F 1998 Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 97: 2502-2505
30. Topol EJ 2001 Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 357: 1905-1914
31. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F 1997 Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278: 2093-2098
32. Zorman S, Zorman D, Noc M 2002 Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 90: 533-536